![]() |
市场调查报告书
商品编码
1954664
全球按钮式安全采血针市场:市场规模、占有率、成长率、产业分析、依类型、应用和地区划分的考察及预测(2026-2034)Button-activated Safety Lancet Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2026-2034 |
||||||
2025年全球按钮式安全采血针市场规模为7.547亿美元,预计2026年将成长至8.4024亿美元。到2034年,该市场预计将达到21.1711亿美元,预测期内年复合成长率(CAGR)为12.25%。
2025年,北美以57.70%的市场占有率引领全球市场。该地区的领先地位得益于其糖尿病的高发病率、完善的医疗保健基础设施以及即时诊断(POC)技术的广泛应用。
按钮式安全采血针是一种抛弃式装置,用于快速刺穿皮肤以采集毛细血管血液样本。只需按下位于顶部或侧面的按钮即可活化,可伸缩的针头或刀片随即伸出,最大限度地减少针刺伤和交叉感染。它们广泛用于血糖监测、血红蛋白检测、胆固醇筛检和其他诊断应用。
市场动态
市场驱动因素
糖尿病盛行率上升和即时检测成长
全球糖尿病负担日益加重是市场扩张的主要驱动因素。频繁的血糖监测需要安全、卫生且易于使用的采血针,尤其是在家庭医疗保健环境中。根据国际糖尿病联盟(IDF)的预测,到2050年,非洲糖尿病患者人数预计将达到 6,000万,比2024年增加 142%。
此外,即时诊断设备的日益普及也推动了市场需求。按钮式安全采血针通常与血糖仪和携带式分析仪搭配使用。农村地区医疗保健服务的普及以及疾病早期检测工作的推进,进一步加速了该产品的推广应用。
市场限制因子
替代采血技术的兴起
持续血糖监测(CGM)系统的日益普及给传统采血针的使用带来了挑战。持续血糖监测(CGM)设备无需频繁扎手指即可提供即时血糖资料,减少对采血针的依赖。
例如,2021年 11月,Intuity Medical 在美国推出了 Pogo 自动血糖监测系统,无需单独购买试纸和采血针。随着微创技术价格的下降,其广泛应用可能会限制传统安全采血针的长期成长。
市场机会
家庭诊断需求不断增加
向家庭医疗保健和远距患者监测的转变带来了强劲的成长机会。疫情之后,老年人和慢性病患者越来越倾向于在家管理自身病情。
根据美国国家生物技术资讯中心(NCBI)于2022年 8月发布的一项研究,加拿大安大略省 80 岁及以上人群的居家血糖检测率从2013年的70%上升至约 80%。按钮式安全采血针以其符合人体工学的设计和易用性而闻名,是满足此需求的理想产品。
市场挑战
认知度低且使用不当
在低收入和中等收入国家,认知度低和使用不当阻碍了采血针的普及。操作不当、试图重复使用以及处置不当都会危及安全。此外,不同品牌采血针的针号和工作压力缺乏标准化,也造成了使用者困扰。
市场趋势
超细规格采血针需求成长
市场对超细规格(28G以上)采血针的需求强劲,目的是减轻疼痛并提高患者舒适度。这些产品尤其受到儿童和老年人的欢迎。
製造商正致力于人体工学设计、直观的操作系统、颜色编码的穿刺深度指示器以及改进的包装,以方便消毒和处置。随着门诊护理和远距医疗服务的扩展,对易于使用的设备的需求持续成长。
依产品类型
市场分为按压式/顶部按钮式和侧边按钮式采血针。
2024年,按压式/顶部按钮式采血针因其操作简便且与血糖仪相容而占据市场主导地位。预计侧边按钮式采血针由于能够更佳控制穿刺深度并减轻手部疲劳,将显着提高其年复合成长率。
依切口类型
市场分为针型和刀片型。
2024年,针型采血针因其疼痛感较低、穿刺力较小而占据市场主导地位。刀片式采血针占据第二大市场占有率,因其更高的样本采集率而受到实验室的青睐。
依年龄组别划分
2024年,成人市场占据主导地位,这主要得益于慢性病的高发生率。由于青少年糖尿病病例的增加和学校健康筛检计划的推进,预计儿童市场将保持稳定成长。
依应用领域划分
2024年,血糖监测领域占据最大市场占有率,这主要得益于糖尿病发生率的上升和家庭检测需求的成长。随着贫血筛检计画的增加,血红素检测的需求也在增加。
依规格划分
2024年,28G以上规格的采血针因其疼痛感更轻、癒合更快而占据市场主导地位。在临床实务中,22G细分市场占据第二大占有率。
依通路划分
到2024年,由于医院药局的大量采购,其市场占有率最大。由于电子商务渗透率的不断提高,预计线上药局将实现最高的年复合成长率。
北美
北美地区凭藉其完善的健保体系和较高的自我监测率,将继续保持其区域主导地位,到2025年市场规模达到2.637亿美元,到2026年将达到2.9197亿美元。
欧洲
在对老年护理和数位医疗的投资支持下,欧洲预计将保持稳定成长。
亚太地区
预计到2034年,亚太地区将实现最高的年复合成长率,这主要得益于中国和印度糖尿病患病率的上升。
拉丁美洲和中东及非洲
预计拉丁美洲将实现显着成长,由于医疗保健服务的改善,预计中东和非洲地区将逐步扩张。
The global button-activated safety lancet market size was valued at USD 754.7 million in 2025 and is projected to grow to USD 840.24 million in 2026. The market is expected to reach USD 2,117.11 million by 2034, registering a CAGR of 12.25% during the forecast period.
North America dominated the global market with a 57.70% share in 2025. The region's leadership is driven by a high prevalence of diabetes, strong healthcare infrastructure, and widespread adoption of point-of-care (POC) diagnostics.
Button-activated safety lancets are single-use devices designed to obtain capillary blood samples through a quick skin puncture. Activated by a push/top or side-positioned button, these devices trigger a retractable needle or blade to minimize needlestick injuries and cross-contamination. They are widely used for blood glucose monitoring, hemoglobin testing, cholesterol screening, and other diagnostic applications.
Market Dynamics
Market Drivers
Rising Diabetes Prevalence and Growth of Point-of-Care Testing
The growing global burden of diabetes is a major driver of market expansion. Frequent blood glucose monitoring requires safe, hygienic, and easy-to-use lancets, particularly in home-care settings. According to the International Diabetes Federation, diabetes prevalence in Africa is projected to reach 60 million by 2050, reflecting a 142% increase compared to 2024 levels.
Additionally, the increasing use of point-of-care diagnostic devices has strengthened demand. Button-activated safety lancets are commonly paired with glucometers and portable analyzers. Expanding rural healthcare access and early disease detection initiatives are further accelerating product adoption.
Market Restraints
Emergence of Alternative Blood Sampling Technologies
The growing adoption of continuous glucose monitoring (CGM) systems poses a challenge to traditional lancet usage. CGM devices provide real-time glucose data without frequent finger pricks, reducing reliance on lancets.
For instance, in November 2021, Intuity Medical launched the Pogo Automatic Blood Glucose Monitoring System in the U.S., eliminating the need for separate strips and lancets. As prices of minimally invasive technologies decline, their adoption may limit the long-term growth of conventional safety lancets.
Market Opportunities
Expanding Demand for Home-Based Diagnostics
The shift toward home healthcare and remote patient monitoring presents strong growth opportunities. Post-pandemic, elderly and chronic patients increasingly prefer managing conditions at home.
A study published on NCBI in August 2022 reported that home glucose testing among individuals aged over 80 years in Ontario, Canada, increased to approximately 80%, compared to 70% in 2013. Button-activated safety lancets, known for ergonomic design and ease of use, are well-positioned to meet this demand.
Market Challenges
Limited Awareness and Improper Usage
In low- and middle-income countries, limited awareness and improper handling practices hinder adoption. Incorrect activation, reuse attempts, or improper disposal can compromise safety. Additionally, lack of standardization in gauge sizes and activation pressures across brands creates confusion among users.
Market Trends
Rising Preference for Ultra-Fine Gauge Lancets
The market is witnessing strong demand for ultra-fine gauge sizes (above 28G) to reduce pain and enhance patient comfort. These variants are particularly popular among pediatric and geriatric populations.
Manufacturers are focusing on ergonomic designs, intuitive activation systems, color-coded depth indicators, and improved packaging for sterility and ease of disposal. As outpatient care and telehealth services expand, demand for user-friendly devices continues to rise.
By Product Type
The market is segmented into push/top button and side button lancets.
The push/top button segment dominated in 2024 due to ease of use and compatibility with glucometers. The side button segment is projected to register a considerable CAGR owing to improved control over puncture depth and reduced hand strain.
By Incision Type
The market is divided into needle and blade.
The needle segment dominated in 2024 due to reduced pain and low penetration force. Blade lancets hold the second-largest share, preferred in laboratories for higher sample yield.
By Age Group
The adult segment dominated in 2024, driven by high prevalence of chronic diseases. The pediatric segment is projected to grow steadily due to rising juvenile diabetes cases and school screening initiatives.
By Application
The blood glucose monitoring segment held the largest share in 2024, supported by rising diabetes incidence and home-based testing demand. Hemoglobin testing is also growing due to increasing anemia screening programs.
By Gauge Size
Lancets above 28G dominated the market in 2024 due to minimal pain and faster healing. The 22G segment held the second-largest share in clinical settings.
By Distribution Channel
Hospital pharmacies accounted for the largest share in 2024 due to bulk procurement. Online pharmacies are expected to register the highest CAGR owing to growing e-commerce penetration.
North America
North America was valued at USD 263.7 million in 2025 and USD 291.97 million in 2026, maintaining regional dominance due to strong reimbursement systems and high self-monitoring adoption.
Europe
Europe is projected to grow steadily, supported by investments in elderly care and digital health.
Asia Pacific
Asia Pacific is expected to witness the highest CAGR through 2034, driven by rising diabetes prevalence in China and India.
Latin America and Middle East & Africa
Latin America is projected to grow significantly, while the Middle East & Africa is expected to experience moderate expansion due to improving healthcare access.
Competitive Landscape
Key players include:
Companies are focusing on product innovation and capacity expansion. In January 2025, BD expanded investments in its U.S. manufacturing network to enhance production of essential medical devices.
Conclusion
The global button-activated safety lancet market, valued at USD 754.7 million in 2025, is projected to grow to USD 840.24 million in 2026 and reach USD 2,117.11 million by 2034, expanding at a CAGR of 12.25%. Growth is driven by rising diabetes prevalence, increasing point-of-care diagnostics, and expanding home-based healthcare adoption. While alternative technologies such as CGM systems present challenges, ongoing product innovation and growing healthcare access in emerging markets are expected to sustain strong market growth through 2034.
Segmentation By Product Type, Incision Type, Age Group, Application, Gauge Size, Distribution Channel, and Region
By Product Type * Push/Top Button
By Incision Type * Needle
By Age Group * Adult
By Application * Blood Glucose Monitoring
By Gauge Size * 22G and Below
By Distribution Channel * Hospital Pharmacies
By Region * North America (By Product Type, Incision Type, Age Group, Application, Gauge Size, Distribution Channel, and Country)